The Medicines Company (Nasdaq:MDCO), a global biopharmaceutical company
focused on hospital care, and SciClone Pharmaceuticals (Nasdaq: SCLN), a
U.S. based, China focused specialty pharmaceutical company, today
announced the establishment of a strategic partnership for two
cardiovascular products in China.

StubHub, the world’s largest ticket marketplace, today announced a brand
new partnership with AudienceView, the complete e-commerce provider for
entertainment organizations worldwide, to serve as a distribution
channel for primary ticketed events.

The
West Virginia Health Innovation Collaborative , formed in an effort
to map a new strategic vision for a healthy and prosperous West
Virginia, announced the launch of a new website www.wvhicollaborative.wv.gov .

Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that Daniel Paterson, Chief Business Officer, has been
appointed to the role of Chief Operating Officer, effective December 12,
2014.

Bellicum Pharmaceuticals, Inc., a biopharmaceutical company focused on
discovering and developing novel cellular immunotherapies, today
announced the pricing of its initial public offering of 7,350,000 shares
of its common stock, an increase of 1,100,000 shares from the number of
shares originally offered, at a public offering price of $19.00 per
share.

http://www.marketwire.com/library/MwGo/2014/12/18/11G028831/8b7f50fa9ea04adf_org-797574636.jpg
WYOMISSING, PA--(Marketwired - December 18, 2014) - Customers Bancorp, Inc. (NASDAQ: CUBI), the parent company of Customers Bank (collectively "Customers" or "Company"), today announced its intention to transfer the listing of its Voting Common Stock, $1 par value per share (the "Voting Common Stock"), and its 6.375% Senior Notes Due 2018 (the "Senior Notes"), from the NASDAQ Global Select Market ("NASDAQ") to the New York Stock Exchange (the "NYSE"). Customers' Voting Common Stock and Senior Notes have been approved for listing on the NYSE and are expected to commence trading on the NYSE on December 30, 2014 under the ticker symbols "CUBI," for the voting common stock, and "CUBS," for the Senior Notes.

Integrated Device Technology, Inc. ( IDT ® )
(NASDAQ:IDTI) announced today that it has shipped over 100 million PCIe
buffers and over 3 million low-power PCIe Gen3 buffers, cementing
its role as a key enabling and validation partner of leading x86 and
ARM-based CPU and chipset suppliers.

The acquired diagnostic technology is intended for the detection of Mycobacterium avium subspecies paratuberculosis (MAP) bacterium; Increasing evidence supports the hypothesis that Crohn's disease is caused by MAP infection in susceptible patients RedHill is developing a MAP diagnostic test in collaboration with Quest Diagnostics, and plans to hold a pre-submission meeting with FDA in January 2015 The MAP diagnostic test is being developed as part of RedHill's development program for RHB-104 - a potentially groundbreaking treatment for Crohn's disease currently undergoing a Phase III study in the U.S., Canada and Israel
TEL-AVIV, Israel, Dec.